Sunshine Biopharma Inc.

NASDAQ: SBFM · Real-Time Price · USD
1.51
0.00 (0.00%)
At close: Aug 15, 2025, 3:06 PM

Sunshine Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.69M 16.29M 21.83M 2.05M
Short-Term Investments
n/a n/a n/a 7.59K
Long-Term Investments
n/a n/a 1.63M n/a
Other Long-Term Assets
n/a n/a -1.93M -7.06K
Receivables
3.87M 2.55M 1.91M 7.8K
Inventory
11.28M 5.73M 3.29M 105.65K
Other Current Assets
n/a n/a n/a 7.59K
Total Current Assets
25.97M 24.89M 27.31M 2.2M
Property-Plant & Equipment
1.48M 1.01M 1.15M 7.06K
Goodwill & Intangibles
3.02M 1.44M 776.86K n/a
Total Long-Term Assets
4.59M 2.46M 1.93M 7.06K
Total Assets
30.56M 27.35M 29.24M 2.2M
Account Payables
5.54M 2.59M 2.8M 42.94K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 3.63M n/a
Other Current Liabilities
295.8K 2.55M n/a n/a
Total Current Liabilities
6.31M 5.55M 6.93M 91.23K
Long-Term Debt
n/a n/a n/a 1.9M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
744.72K 587.76K 685.26K 1.9M
Total Liabilities
7.06M 6.14M 7.62M 1.99M
Total Debt
952.48K 657.71K 4.27M 1.9M
Common Stock
2.58K 28.02K 22.59K 2.59K
Retained Earnings
-69.04M -63.91M -59.4M -32.66M
Comprehensive Income
-829.96K 696.11K 161.85K -23.14K
Shareholders Equity
23.5M 21.21M 21.63M 211.66K
Total Investments
n/a n/a 1.63M 7.59K